Avadel Pharmaceuticals Plc (AVDL)
21.39
-0.09
(-0.42%)
USD |
NASDAQ |
Dec 11, 16:00
21.38
0.00 (0.00%)
After-Hours: 20:00
Avadel Pharmaceuticals Research and Development Expense (Quarterly): 27.01M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alkermes Plc | 80.34M |
| Jazz Pharmaceuticals Plc | 198.20M |
| Medtronic Plc | 754.00M |
| STERIS Plc (Ireland) | 28.20M |
| Amarin Corp. Plc | 3.321M |